Lisa Deaton
Overview
Explore the profile of Lisa Deaton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Searleman A, Ma Y, Sampath S, Sampath S, Bussell R, Chang E, et al.
Front Neuroimaging
. 2024 May;
3():1356713.
PMID: 38783990
Purpose: To test the ability of inversion-recovery ultrashort echo time (IR-UTE) MRI to directly detect demyelination in mice using a standard cuprizone mouse model. Methods: Non-aqueous myelin protons have ultrashort...
2.
Liu Y, Jin Q, Ding Q, Hao X, Mo T, Yan S, et al.
ChemMedChem
. 2020 Jul;
15(16):1562-1570.
PMID: 32613743
Loss of β-cell mass and function can lead to insufficient insulin levels and ultimately to hyperglycemia and diabetes mellitus. The mainstream treatment approach involves regulation of insulin levels; however, approaches...
3.
Liu Y, Jin Q, Zou Y, Ding Q, Yan S, Wang Z, et al.
J Med Chem
. 2020 Feb;
63(6):2958-2973.
PMID: 32077280
Autoimmune deficiency and destruction in either β-cell mass or function can cause insufficient insulin levels and, as a result, hyperglycemia and diabetes. Thus, promoting β-cell proliferation could be one approach...
4.
Shen W, Taylor B, Jin Q, Nguyen-Tran V, Meeusen S, Zhang Y, et al.
Nat Commun
. 2015 Oct;
6:8372.
PMID: 26496802
Insufficient pancreatic β-cell mass or function results in diabetes mellitus. While significant progress has been made in regulating insulin secretion from β-cells in diabetic patients, no pharmacological agents have been...